[ad_1]
AI-enabled voice know-how platform Sonde Well being introduced it raised $19.25 million in a Collection B funding spherical led by Companions Funding, bringing its complete elevate to $35.25 million.
KT Company, NEOM Firm and present buyers additionally participated within the spherical, together with cofounder PureTech Well being and M Ventures.
WHAT IT DOES
Sonde Well being makes use of patented voice know-how to detect numerous well being circumstances from biomarkers in an individual’s voice, together with analyzing respiratory health and detecting melancholy and anxiousness.
WHAT IT’S FOR
The funding will assist construct out the corporate’s know-how to detect extra well being circumstances, broaden its present respiratory and psychological health-monitoring applied sciences, and drive international business development.
“Digital biomarkers have gotten a mainstay in healthcare. At present’s healthcare firms are realizing how vocal biomarkers can interact folks earlier of their well being. The information and insights present in voice can energy well being monitoring and affected person stratification so points can turn into obvious properly earlier than a pricey medical occasion happens,” David Liu, CEO of Sonde Well being, mentioned in a press release.
“With voice and any listening machine, accessible and efficient well being monitoring could be made out there to nearly all of the world.”
MARKET SNAPSHOT
Final month, Boston-based Sonde Well being garnered a $2 million strategic funding from South Korean telecommunications large KT Company. KT plans to make use of the tech to improve its AI-powered voice enterprise options and combine Sonde’s know-how into its telemedicine platform in Vietnam.
Sonde Well being licensed its voice know-how from MIT’s Lincoln Laboratory and in 2018 obtained unique licensing agreements for the patent.
In 2020, the corporate launched its voice API to detect psychological sickness, saying that the device can detect vocal modifications that would sign one’s psychological state through 30-second audio clips and that it could possibly be built-in into third-party apps.
Throughout the peak of the pandemic, it launched a vocal-screening device to detect respiratory sickness signs and purchased voice-based platform-maker NeuroLex Laboratories.
